ACR Convergence 2023 will be held in San Diego in November.
Rheumatologists and rheumatology professionals, whether they are primarily academics or clinicians, are affected by decisions made by politicians and others who don’t necessarily understand the impact their choices make on the people they represent and serve. One of the primary benefits of ACR/ARP membership is the advocacy efforts expended on behalf of physicians, care team members and patients to steer public policy on your behalf. The ACR has professional staff and dedicated volunteers lobbying for the interests of the rheumatology community in the U.S. Congress, at federal regulatory agencies, your state capitol and with private payers.
On Nov. 12, 9–10 a.m., the ACR Legislative & Public Policy Update session at ACR Convergence 2023 will introduce those individuals and update attendees on current public policy that may impact their work, including cuts to Medicare reimbursement, prior authorization reform, step therapy reform, prescription drug pricing, supporting the medical workforce, adjusting to biosimilars, the evolution of telehealth and federal funding for biomedical research.
